Strengthening Hesse as a driver of innovation

What are the conditions for maintaining and strengthening Hesse's importance and influence as a driver of innovation? This week, against the backdrop of current EU legislation, representatives from science and the biotech industry discussed this topic with members of the state of Hesse and the European Commission at an event organized by the Health Industry Initiative Hesse (IGH) in Brussels.

Invited guests included members of the European Parliament, international biotech and pharmaceutical associations, entrepreneurs and their representatives in Brussels. Martina Schneider, Chief of Staff at CSL Innovation GmbH - CSL's research and development entity in Marburg - represented the Marburg site and its requirements for continued innovation and sustainable sustainable future growth. “We are building a biomedical incubator on CSL's R&D campus in Marburg, providing 800 square meters of laboratory space for local start-ups,” says Schneider. ”In addition, we are actively involved in implementing an innovation hub on the Behringwerke campus and a life science ecosystem in the region.”

What is being striven for in the local ecosystem must also work at the international level: “In order to survive in international competition beyond state and federal borders, a stable legal framework for research and development is essential,” says Schneider. “Specifically, the harmonization of regulations, access to funding, attractive conditions for international talent and the transfer of scientific knowledge to industry play a crucial role here, for example.”